Gender | Age
Item
male patients greater than 18 years of age
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes mellitus
boolean
C0011860 (UMLS CUI [1])
Serum testosterone measurement CONSECUTIVE SAMPLE Quantity
Item
serum testosterone less than 11 nmol/l on two consecutive samples taken on different days
boolean
C0428413 (UMLS CUI [1,1])
C0150094 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Peripheral Vascular Disease Ankle brachial pressure index | Pain in lower limb Ischemic | Claudication | Rest pain | Complication Distal | FOOT ULCER UNHEALED Arterial | Gangrene Non-healed
Item
peripheral vascular disease as defined by abpi less than 0.92 and ischaemic leg pain (claudication or rest pain) or distal complications (non-healing arterial foot ulcer or gangrene
boolean
C0085096 (UMLS CUI [1,1])
C1276055 (UMLS CUI [1,2])
C0023222 (UMLS CUI [2,1])
C0475224 (UMLS CUI [2,2])
C1456822 (UMLS CUI [3])
C0234253 (UMLS CUI [4])
C0009566 (UMLS CUI [5,1])
C0205108 (UMLS CUI [5,2])
C0744185 (UMLS CUI [6,1])
C0221464 (UMLS CUI [6,2])
C0017086 (UMLS CUI [7,1])
C0205301 (UMLS CUI [7,2])
Antihypertensive therapy Dosage Maintenance | Antilipidemic Agent Dosage Maintenance
Item
agreement to maintain antihypertensive and anti-lipid treatments at prior doses during 3 months of study
boolean
C0585941 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0024501 (UMLS CUI [1,3])
C1516000 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0024501 (UMLS CUI [2,3])
Informed Consent
Item
ability to give written informed consent after verbal and written explanation in the english language
boolean
C0021430 (UMLS CUI [1])
Protocol Compliance
Item
ability to comply with all study requirements
boolean
C0525058 (UMLS CUI [1])
Breast Carcinoma
Item
current or previous breast cancer
boolean
C0678222 (UMLS CUI [1])
Prostate carcinoma
Item
current or previous prostate cancer
boolean
C0600139 (UMLS CUI [1])
Raised prostate specific antigen | Prostate specific antigen abnormal Rectal examination | Prostate carcinoma Exclusion
Item
raised prostate specific antigen or abnormal per rectal examination unless prostate cancer excluded after specialist urology opinion
boolean
C0178415 (UMLS CUI [1])
C0580555 (UMLS CUI [2,1])
C0199900 (UMLS CUI [2,2])
C0600139 (UMLS CUI [3,1])
C2828389 (UMLS CUI [3,2])
Benign prostatic hypertrophy Symptom severe
Item
severe symptoms of benign prostatic hypertrophy ('prostatism')
boolean
C1704272 (UMLS CUI [1,1])
C0436345 (UMLS CUI [1,2])
Testosterone
Item
treatment with testosterone in the 3 months prior to the trial
boolean
C0039601 (UMLS CUI [1])
Investigational New Drugs
Item
investigational drug treatment in the 3 months prior to the trial
boolean
C0013230 (UMLS CUI [1])